(αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid manufacturers
- UBP-282
-
- $1980.00
-
2026-05-11
- CAS:544697-47-4
- Purity:
- Supply Ability: 10g
|
| | (αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid Basic information |
| Product Name: | (αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid | | Synonyms: | UBP 282 HCL;(αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoicacid;UBP 282;(aS)-a-Amino-3-((4-carboxyphenyl)methyl)-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoicacid;(alphaS)-alpha-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid;1(2H)-Pyrimidinepropanoic acid, α-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-, (αS)-;(αS)-α-Amino-3-[(4-carboxyphenyl)meth
yl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoi
c acid;UBP282,UBP 282 | | CAS: | 544697-47-4 | | MF: | C15H15N3O6 | | MW: | 333.3 | | EINECS: | | | Product Categories: | Glutamate receptor | | Mol File: | 544697-47-4.mol | ![(αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid Structure](CAS/GIF/544697-47-4.gif) |
| | (αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid Chemical Properties |
| storage temp. | Store at RT | | solubility | Soluble to 100 mM in 1eq. NaOH and to 25 mM in 1eq. HCl | | form | Powder |
| | (αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid Usage And Synthesis |
| Uses | UBP 282 is a receptor antagonist that distinguishes between motoneuron and dorsal root kainate receptors. | | Biological Activity | AMPA and kainate receptor antagonist. Inhibits AMPA receptor-, but not kainate receptor-mediated currents on spinal neonatal motoneurons yet antagonizes kainate-induced responses on dorsal root C-fibres. | | in vivo | On neonatal rat motoneurones UBP-282 (3-CBW) (200 μM) almost completely abolished responses to AMPA while responses to NMDA, kainate and DHPG were 101.6%, 39.4% and 110.5% of control, respectively. UBP-282 can therefore be used to isolate kainate receptor responses from those mediated by AMPA receptors[1]. |
| | (αS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid Preparation Products And Raw materials |
|